Sathyanarayanan Sriram

Chief Scientific Officer at Codiak BioSciences, Inc.

Sold, on record
$63k
Dollars the filings state
Form 4 sales
4
Latest Mar 29, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Codiak BioSciences, Inc.Unusual
    Aug 9, 2021 2021

    Sold 2,600 shares at $20.84 ($54k)

    Sathyanarayanan Sriram, Chief Scientific Officer

    Sold 100% of holdings ($54k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Codiak BioSciences, Inc.Unusual
    Jan 20, 2023 +529 days

    Sold 1,082 shares at $0.58 ($628)

    Sathyanarayanan Sriram, Chief Scientific Officer

    Sold 38.2% of holdings ($2k position)1,752 shares leftFiling

  3. 3 Form 4 sale Codiak BioSciences, Inc.Unusual
    Feb 17, 2023 +28 days

    Sold 4,690 shares at $1.38 ($6k)

    Sathyanarayanan Sriram, Chief Scientific Officer

    Sold 28.5% of holdings ($23k position)11,762 shares leftFiling

  4. 4 Form 4 sale Codiak BioSciences, Inc.Unusual
    Mar 29, 2023 +40 days

    Sold 11,762 shares at $0.17 ($2k)

    Sathyanarayanan Sriram, Chief Scientific Officer

    No 10b5-1 planSold 100% of holdings ($2k position)0 shares left4.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Sathyanarayanan Sriram
Source
Mar 29, 2023Mar 30, 2023Codiak BioSciences, Inc.Chief Scientific OfficerForm 4 sale11,762$2k100.0%UnusualSEC
Feb 17, 2023Feb 21, 2023Codiak BioSciences, Inc.Chief Scientific OfficerForm 4 sale4,690$6k28.5%UnusualSEC
Jan 20, 2023Jan 23, 2023Codiak BioSciences, Inc.Chief Scientific OfficerForm 4 sale1,082$62838.2%UnusualSEC
Aug 9, 2021Sep 28, 2021Codiak BioSciences, Inc.Chief Scientific OfficerForm 4 sale2,600$54k100.0%UnusualSEC